These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34732430)

  • 1. Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer.
    Blas L; Ieiri K; Shiota M; Nagakawa S; Tsukahara S; Matsumoto T; Kashiwagi E; Takeuchi A; Inokuchi J; Shiga KI; Yokomizo A; Eto M
    Anticancer Res; 2021 Nov; 41(11):5593-5598. PubMed ID: 34732430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer.
    Blas L; Shiota M; Yamada S; Ieiri K; Nagakawa S; Tsukahara S; Matsumoto T; Kashiwagi E; Takeuchi A; Inokuchi J; Shiga KI; Yokomizo A; Eto M
    Anticancer Res; 2021 Aug; 41(8):3885-3889. PubMed ID: 34281850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute.
    Miyake M; Tanaka N; Asakawa I; Hori S; Morizawa Y; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Hasegawa M; Fujii T; Konishi N; Fujimoto K
    BMC Urol; 2017 Aug; 17(1):62. PubMed ID: 28806948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?
    Ieiri K; Shiota M; Kashiwagi E; Takeuchi A; Takahashi R; Inokuchi J; Iwai H; Shiga KI; Yokomizo A; Yoshitake T; Shioyama Y; Ishigami K; Terashima H; Eto M
    Urol Oncol; 2020 Dec; 38(12):931.e1-931.e7. PubMed ID: 32900626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience.
    Ito M; Makita C; Mori T; Takano H; Kumano T; Matsuo M; Iinuma K; Kawase M; Nakane K; Nakano M; Koie T
    Curr Oncol; 2023 Jun; 30(6):5680-5689. PubMed ID: 37366909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of serum 25-OH vitamin D level on lower urinary tract symptoms in men: a step towards reducing overactive bladder.
    Yoo S; Oh S; Kim HS; Choi HS; Park J; Cho SY; Son H; Jeong H; Lee HW; Cho MC
    BJU Int; 2018 Oct; 122(4):667-672. PubMed ID: 29745000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
    Washino S; Hirai M; Saito K; Kobayashi Y; Arai Y; Miyagawa T
    Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
    Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
    Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on lower urinary tract symptoms (LUTS) in elderly patients with prostate cancer (PC) received endocrine therapy.
    Sun S; Bai Y; Yang H; Yang HW
    Arch Gerontol Geriatr; 2015; 60(3):535-7. PubMed ID: 25669858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.
    Axcrona K; Aaltomaa S; da Silva CM; Ozen H; Damber JE; Tankó LB; Colli E; Klarskov P
    BJU Int; 2012 Dec; 110(11):1721-8. PubMed ID: 22500884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved lower urinary tract symptoms after robot-assisted radical prostatectomy: implications for survivorship, treatment selection and patient counselling.
    Ahn T; Roberts MJ; Strahan A; Malone G; Paterdis J; Wood G; Heathcote P
    BJU Int; 2019 May; 123 Suppl 5():47-53. PubMed ID: 31012991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Prostatic Symptom Score-voiding/storage subscore ratio in association with total prostatic volume and maximum flow rate is diagnostic of bladder outlet-related lower urinary tract dysfunction in men with lower urinary tract symptoms.
    Jiang YH; Lin VC; Liao CH; Kuo HC
    PLoS One; 2013; 8(3):e59176. PubMed ID: 23527124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal extension in lymph node-positive prostate cancer.
    Cheng L; Pisansky TM; Ramnani DM; Leibovich BC; Cheville JC; Slezak J; Bergstralh EJ; Zincke H; Bostwick DG
    Mod Pathol; 2000 Feb; 13(2):113-8. PubMed ID: 10697266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between lower urinary tract symptoms and cardiovascular risk scores in ostensibly healthy women.
    Lee HY; Moon JE; Sun HY; Doo SW; Yang WJ; Song YS; Lee SR; Park BW; Kim JH
    BJU Int; 2019 Apr; 123(4):669-675. PubMed ID: 30281886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer.
    Tsuchida K; Inaba K; Kashihara T; Murakami N; Okuma K; Takahashi K; Igaki H; Nakayama Y; Maejima A; Shinoda Y; Matsui Y; Komiyama M; Fujimoto H; Ito Y; Sumi M; Nakano T; Itami J
    Cancer Med; 2020 Sep; 9(18):6629-6637. PubMed ID: 32750234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degarelix Versus Goserelin Plus Bicalutamide in the Short-Term Relief of Lower Urinary Tract Symptoms in Prostate Cancer Patients: Results of a Pooled Analysis.
    Mason M; Richaud P; Bosnyak Z; Malmberg A; Neijber A
    Low Urin Tract Symptoms; 2017 May; 9(2):82-88. PubMed ID: 28394498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Gleason scores of lymph node metastases on prognosis of patients with prostate cancer.
    Ko K; Jeong IG; Choi WS; Lim JH; Suh JH; Ku JH; Park Y; Moon KC; Kim HH; Kim CS; Kwak C
    Int J Clin Exp Pathol; 2014; 7(9):6141-8. PubMed ID: 25337262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.